This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) with potential anti-inflammatory or analgesic properties. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting compounds, making it valuable in drug discovery. Additionally, it serves as a key building block in organic synthesis for creating complex molecules with specific biological activities. Its application extends to research in medicinal chemistry, where it is used to explore new therapeutic agents targeting various diseases.